Gazmend Temaj | Pharmacy | Best Researcher Award

Prof. Gazmend Temaj | Pharmacy | Best Researcher AwardūüŹÜ

University for Business and Technology, Albania

Author Profile

Early Academic Pursuits:

Gazmend Temaj embarked on his academic journey with a Bachelor's degree in General Biology and Molecular biologyfrom the University of Pristina in 1998. This foundational education provided him with a solid understanding of the fundamental principles of biology, setting the stage for his subsequent achievements in the field of genetics and biomedicine. He furthered his education with a Master of Sciences degree from the University of Zagreb/Sarajevo in 2004, where he delved deeper into subjects such as genetic populations, molecular biology, and biochemistry. This postgraduate study equipped him with specialized knowledge and skills necessary for his future endeavors in the realm of genetics.

Professional Endeavors:

Throughout his career, Gazmend Temaj has held various positions in prestigious institutions around the world, showcasing his expertise in molecular biology, cytogenetics, and clinical genetics. From his role as a Prof. Assistant at the Medical Faculty in Kosovo to his guest doctor positions at institutions like Goethe Uniklinik in Frankfurt and University Rezonanca in Prishtina, Temaj has consistently demonstrated his proficiency in a wide array of molecular techniques, including ELISA, PCR, gel electrophoresis, and cell culture. His contributions extend beyond his academic appointments, as evidenced by his participation in international conferences and collaborations with renowned institutes such as the Human Genetic Institute in Jena, Germany, and the DEBRA Institute at Salzburg University Clinic in Austria.

Contributions and Research Focus:

His research interests primarily revolve around rare genetic diseases, with a particular focus on Epidermolysis Bullosa (EB). His dissertation on the molecular environment and expression strategy of the therapeutic target RpL35/uL29 in EB underscores his dedication to unraveling the complexities of this debilitating condition. His presentations at international summer academies and conferences highlight his commitment to raising awareness and sharing insights into the management, therapy, and genetic implications of rare diseases, including ribosomopathies and carcinogenic diseases. Temaj's involvement in professional organizations such as ANUBIH, the Albanian Association of Human Molecular Genetics, and membership in consortia like PharmVar and CPIC further attest to his active engagement in advancing the field of genetics and personalized medicine.

Accolades and Recognition:

His contributions to the field have been recognized through invitations to review for esteemed journals and his participation in conferences as an invited lecturer. His commitment to excellence is evident in his pursuit of continuous education, as demonstrated by his completion of courses like the Clinical Laboratory Genetics program in Zagreb, Croatia, and his attendance at webinars on oncology NGS testing.

Impact and Influence:

Through his research, teaching, and professional engagements, Gazmend Temaj has made significant contributions to the field of genetics and biomedicine. His expertise, combined with his passion for advancing knowledge and improving patient care, continues to inspire colleagues and students alike.

Legacy and Future Contributions:

As Gazmend Temaj continues his journey in academia and research, his legacy will be defined by his dedication to unraveling the mysteries of rare genetic diseases and his efforts to translate scientific discoveries into tangible benefits for patients. His future contributions are poised to further enrich our understanding of human genetics and pave the way for innovative therapies and personalized medicine approaches.


A total of  112 citations for his publications, demonstrating the impact and recognition of his research within the academic community.

  • Citations¬† ¬† ¬† ¬† ¬† 112
  • h-index¬† ¬† ¬† ¬† ¬† ¬† ¬† 7
  • i10-index¬† ¬† ¬† ¬† ¬† ¬†5

Notable Publications 

Ribosome-directed therapies in cancer

The impact of consanguinity on human health and disease with an emphasis on rare diseases

Comparative analysis of dermatoglyphic traits in Albanian and Turkish population living in Kosovo

Joubert syndrome: Molecular basis and treatment

Comparative analysis of qualitative dermatoglyphic traits of Albanian and Turkish populations living in the area of Dukagjin Valley in Kosovo

Mucopolysaccharidosis III: Molecular basis and treatment

Three patterns of inheritance of quantitative dermatoglyphic traits: Kosovo albanian twin study

Suspicions regarding the genetic inheritance of acute lymphoblastic leukemia in patients with down syndrome

Correlation between level of vitamin D in serum and value of lung function in children diagnosed with bronchial asthma

Case Report: Identification of likely recurrent CEP290 mutation in a child with Joubert syndrome and cerebello-retinal-renal features.


Maged Abdel-Kader | Pharmacognosy | Excellence in Research

Prof. Maged Abdel-Kader | Pharmacognosy | Excellence in Research

Prince Sattam Bin Abdulaziz University, Saudi Arabia

Author Profile

Early Academic Pursuits

Maged Saad Abdel-Kader's academic journey commenced at Abasia Secondary School from 1977 to 1979. He then pursued his higher education at the College of Pharmacy, University of Alexandria, Egypt, from 1979 to 1984, laying the groundwork for his future endeavors in pharmaceutical sciences.

Professional Endeavors

His professional career is marked by a rich tapestry of experiences. Starting as a Demonstrator in the Department of Pharmacognosy at the College of Pharmacy, University of Alexandria, Egypt, he progressed to various roles including Assistant Lecturer, Lecturer, and eventually becoming a Professor of Phytochemistry, Pharmacognosy, and Applied Pharmacognosy at the Faculty of Pharmacy, University of Alexandria, Egypt.

Contributions and Research Focus

Throughout his career, Abdel-Kader has been dedicated to advancing the field of pharmacognosy and phytochemistry. His research focus spans the chemical study of medicinal plants, with particular emphasis on families like Solanaceae, Zygophyllaceae, Asclepiadaceae, and Scrophulariaceae. His work has contributed significantly to understanding the therapeutic potential of natural products.

Accolades and Recognition

His contributions have been widely recognized, earning him prestigious awards such as the Scientific Encouragements Award from the University of Alexandria and the Sattam Bin Abdulaziz University Award for the best researcher in 2016-2017.

Impact and Influence

His research findings and teachings have had a profound impact on the field of pharmacognosy and the broader pharmaceutical community. Abdel-Kader's work has inspired generations of students and researchers, shaping the way medicinal plants are studied and utilized for therapeutic purposes.

Legacy and Future Contributions

As a respected Professor and researcher, He continues to mentor students and lead groundbreaking research initiatives. His legacy lies not only in his academic achievements but also in his commitment to advancing scientific knowledge and improving healthcare through the exploration of natural products. His future contributions are poised to further enrich the field of pharmacognosy, leaving a lasting imprint on the discipline and its applications in medicine.


A total of  3229 citations for his publications, demonstrating the impact and recognition of his research within the academic community.

  • Citations¬† ¬† ¬† ¬† ¬† ¬† 3229
  • h-index¬† ¬† ¬† ¬† ¬† ¬† ¬† 29
  • i10-index¬† ¬† ¬† ¬† ¬† ¬†101

Notable Publications 

Olive leaves extract attenuates type II diabetes mellitus-induced testicular damage in rats: Molecular and biochemical study
GA Soliman, AS Saeedan, RF Abdel-Rahman, HA Ogaly, ...
{53} 2019

DNA-Damaging Steroidal Alkaloids from Eclipta alba from the Suriname Rainforest
MS Abdel-Kader, BD Bahler, S Malone, MCM Werkhoven, F van Troon, ...
[99] 1998

Two Bioactive Saponins from Albizia subdimidiata from the Suriname Rainforest
M Abdel-Kader, J Hoch, JM Berger, R Evans, JS Miller, JH Wisse, ...
[90] 2001
Prenylated flavonoids of Erythrina lysistemon grown in Egypt
S El-Masry, ME Amer, MS Abdel-Kader, HH Zaatout
[87] 2002
Solubility of bioactive compound hesperidin in six pure solvents at (298.15 to 333.15) K
MK Anwer, R Al-Shdefat, S Jamil, P Alam, MS Abdel-Kader, F Shakeel
[80] 2014
Bioactive Saponins from Acacia tenuifolia from the Suriname Rainforest
Y Seo, J Hoch, M Abdel-Kader, S Malone, I Derveld, H Adams, ...
[76] 2002
Antimicrobial isoflavans from Astragalus species
NA El-Sebakhy, AM Asaad, RM Abdallah, SM Toaima, MS Abdel-Kader, ...
[68] 1994
Terpenes and flavonoids from an Egyptian collection of Cleome droserifolia
MI Aboushoer, HM Fathy, MS Abdel-Kader, G Goetz, AA Omar
[63] 2010